Project Grant R01AR084717
Award Date
8/15/24
Completion Date
6/30/28
Dollars Obligated
$206K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Cincinnati, OH 45229, USA
Similar Awards
This $375,100 Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund a 2-year longitudinal study to characterize the role of the mucosal virome and microbiome in juvenile idiopathic arthritis (JIA) flares. The study will enroll 35 children with JIA and 35 healthy sibling controls, conducting weekly nasal swabs to assess for respiratory viral...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund research to develop patient-driven outcome measures and an N-of-1 clinical trial design to evaluate therapies for Childhood Sjogren's Disease (CSD), a rare autoimmune condition affecting children. The $297,940 award, effective August 15, 2024 through July 31, 2026, will be administered...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $212,574 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to Seattle Children's Hospital, operating as the Seattle Children's Research Institute. The grant will fund a 5-year mentorship program led by Dr. Shaun Jackson to train the next generation of researchers in pediatric autoimmunity. The program will provide structured training, individualized...
This federal Project Grant award, valued at $194,700.00 and funded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to characterize the biobehavioral basis of cognitive dysfunction in childhood-onset systemic lupus erythematosus (cSLE). The research aims to investigate functional central nervous system properties, white matter microstructure, and...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Medical University of South Carolina (MUSC) a $365,420 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to study the role of the SLE causal variant NCF1.PR90H in promoting kidney damage. The 2-year project aims to investigate how this genetic variant impacts the function of the NADPH oxidase complex and contributes to systemic lupus erythematosus...
This Project Grant award of $788,508 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) supports research into the links between cutaneous photosensitivity, systemic autoimmunity, and lymphatic dysfunction in systemic lupus erythematosus (SLE). The research aims to delineate the determinants of Langerhans cell (LC) licensing for lymphatic regulation, identify the...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), totals $216,113 and is aimed at investigating the mechanism of hematological abnormalities in systemic autoimmunity. The research, to be conducted by New York University School of Medicine, will characterize the impairment of hematopoietic stem cells (HSCs) in a mouse model of systemic lupus...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $375,100 to The Johns Hopkins University to conduct research on the interplay between nucleic-acid-dependent phase separation and immune responses against cGAS in systemic lupus erythematosus (SLE). The goal is to elucidate how biophysical changes triggered by cGAS activation...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $599,693 to support research at the Hospital for Special Surgery Fund, Inc. (doing business as HSS Foundation) to elucidate molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis under pathological inflammatory conditions. The research aims to...
This $462,131 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports transformative behavioral health research to improve quality of life for individuals with childhood-onset lupus. The prime awardee, The Hospital for Sick Children (Sick Kids Hospital) in Toronto, Canada, will lead this 4-year initiative. As a leading pediatric research hospital, Sick Kids Hospital has extensive experience as a subcontractor on...